Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

491 results about "Bronchial epithelium" patented technology

Bronchial epithelium is a key element of the respiratory airways. It constitutes the interface between the environment and the host. It is a physical barrier with many chemical and immunological properties. The bronchial epithelium is abnormal in asthma, even in children.

Small target detection method, system and device for medical image and storage medium

The invention discloses a small target detection method, system and device for a medical image and a storage medium, and the method comprises the steps: constructing a small target detection model of a bronchial medical image, which comprises a backbone network, a neck network and a prediction network, and introducing a residual network and a cavity space convolution pooling pyramid into the backbone network; introducing a global attention module into the neck network; inputting the preprocessed bronchial medical image into the backbone network, performing detail feature supplementation by adopting a residual network and enhancing a receptive field by adopting a void space convolution pooling pyramid to obtain feature maps of various scales output by the backbone network; inputting the multi-scale feature maps into a neck network, and performing global information enhancement by adopting a global attention module to obtain multi-scale tensor data output by the neck network; and carrying out feature fusion on the tensor data of multiple scales by adopting a prediction network, and carrying out small target detection on the fused features. According to the invention, the accuracy of small target detection can be improved.
Owner:CHANGSHA UNIVERSITY OF SCIENCE AND TECHNOLOGY

Methods for treating or preventing asthma by administering an IL-4R antagonist

Methods for treating or preventing asthma (e.g., allergic asthma, asthma associated with allergic bronchopulmonary aspergillosis (ABPA), moderate-to-severe asthma, persistent asthma or the like) and associated conditions (e.g., ABPA, ABPA comorbid with asthma, ABPA comorbid with cystic fibrosis (CF), ABPA comorbid with asthma and CF) in a subject are provided. Methods comprising administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or antigen-binding fragment thereof, are provided.
Owner:SANOFI BIOTECH SAS +1

Nitric oxide data analysis method and system for bronchial asthma assessment

The invention relates to a nitric oxide data analysis method and system for bronchial asthma assessment. According to the method, exhaled air nitric oxide and pulmonary alveolar nitric oxide of a patient, omics data and clinical information are acquired in a standardized manner, and multi-dimensional features are constructed after data cleaning and fusion; comprise an inflammation level index, an inflammation region entropy, an inflammation synergy index, a glucocorticoid response factor, an infection-smoking synergy influence factor and a heredity-symptom distribution index. And outputting initial risk assessment based on an explainable elevator EBM model, and finally generating an asthma risk probability through a weighted integration formula to realize three-level layering: low / medium / high risk. The system dynamically associates treatment decisions, for example, the drug dosage and the monitoring frequency are improved when the risk is upgraded, and the medication scheme is optimized when the risk is degraded. According to the scheme, the limitation of traditional single marker static analysis is broken through, multiple mechanisms of dissection, immunity and pharmacology are fused, the evaluation precision and clinical applicability are remarkably improved, the acute attack rate is reduced, and accurate typing treatment is guided.
Owner:FUDING CITY HOSPITAL

Method and system for assisting bronchus endoscope microscopic examination, electronic equipment and storage medium

The invention discloses a method and system for assisting bronchus endoscope microscopic examination, electronic equipment and a storage medium. The method comprises the following steps: acquiring a bronchus endoscope examination image in real time; operating a first pre-trained classifier to classify the bronchus endoscopic examination image, wherein the bronchus endoscopic examination image comprises mark identification information used for identifying at least two inner cavities; in response to the classified bronchus endoscope examination image, obtaining an identification result of the bronchus endoscope examination image, and calling a state request for obtaining the microscopic examination condition of the bronchus endoscope; and feeding back the real-time microscopic examination condition of the bronchus endoscope according to the state request. According to the scheme, the current position of the bronchoscope can be intelligently identified by utilizing the bronchus tree model, so that a doctor is assisted in judging and updating the position of the bronchoscope, missing detection of a key position or wrong detection of other positions can be prevented, meanwhile, the microscopic examination operation level, the examination image quality and the like are evaluated in real time, and the operation efficiency is improved. Therefore, the reliability and the accuracy of bronchoscopy results are improved.
Owner:THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV (GUANGZHOU RESPIRATORY CENT) +1

Intelligent medical data processing system and method based on artificial intelligence

The invention relates to the technical field of medical data processing, and particularly discloses an intelligent medical data processing system and method based on artificial intelligence, and the system employs an image processing technology based on deep learning to carry out the multi-level feature extraction of a reexamination CT scanning image of a chronic disease patient. Texture features and structural features of a bronchiectasis area in a CT scanning image are mined, and fine-grained semantic interactive fusion based on core association features is performed on the texture features and the structural features of the bronchiectasis state, so that comprehensive understanding of the bronchiectasis state is realized, and then the bronchiectasis type of bronchiectasis is intelligently identified. Therefore, the identification precision of the bronchiectasis type can be effectively improved, and a more accurate diagnosis basis is provided for doctors.
Owner:THE FIRST AFFILIATED HOSPITAL OF MEDICAL COLLEGE OF XIAN JIAOTONG UNIV

Humanized bronchial organ and construction method thereof

PendingCN119020261AGood three-dimensional structurehelp with simulationVertebrate cellsArtificial cell constructsImmunofluorescenceIntermediate cell
The invention discloses a human bronchus organoid and a construction method thereof, and belongs to the technical field of organoid culture. Comprising the following steps: (1) culturing human bronchial epithelial cells in a human bronchial epithelial cell complete medium, and when the cell density grows to 90%, carrying out passage according to a ratio of 1: 2; (2) culturing the subcultured human bronchial epithelial cells in an airway organ proliferation culture medium to obtain an intermediate cell sphere; and (3) culturing the intermediate cell spheres in an airway organoid differentiation medium to obtain the human bronchial organoid. Compared with cells, the human bronchial organ provided by the invention has a better three-dimensional structure, can well express various markers in airway epithelium, and is beneficial to simulation of a real in-vivo environment. Immunofluorescence identification shows that the organ well expresses various markers of airway tissues, standardized batch culture is facilitated, and the bronchial organ is used for simulating an in-vivo environment to perform various tests.
Owner:CAPITAL UNIVERSITY OF MEDICAL SCIENCES

Auxiliary diagnosis method and system for bronchial asthma

The invention discloses an auxiliary diagnosis method and system for bronchial asthma, and relates to the technical field of molecular diagnosis prediction.The auxiliary diagnosis method comprises the steps that an experimental group and a control group are defined, and RNA of the experimental group and RNA of the control group are extracted for low-temperature preservation; carrying out quantitative PCR (Polymerase Chain Reaction) analysis on the RNA stored at low temperature and extracting target cDNA; collecting clinical data of the experimental group and calculating the corresponding biomarker concentration according to the target cDNA; and constructing a bronchial asthma prediction model, outputting a predicted risk probability value of each patient suffering from asthma, and dynamically classifying and adjusting the treatment schemes of the patients. RNA samples of an experimental group and a control group are accurately extracted and stored, remarkably changed gene expression is obtained in combination with quantitative PCR analysis, the gene expression is further combined with biomarker concentration, dynamic monitoring of the asthma-related inflammatory response is successfully achieved, and the bronchial asthma risk of a patient can be accurately evaluated by constructing a bronchial asthma prediction model. And a personalized treatment scheme is provided according to comprehensive analysis of gene expression and biomarkers.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE

Systems for treating pulmonary infections

Provided herein are systems for treating a subject with a pulmonary infection, for example, a nontuberculous mycobacterial pulmonary infection, a Burkholderia pulmonary infection, a pulmonary infection associated with bronchiectasis, or a Pseudomonas pulmonary infection. The system includes a pharmaceutical formulation comprising a liposomal aminoglycoside dispersion, and the lipid component of the liposomes consist essentially of electrically neutral lipids. The system also includes a nebulizer which generates an aerosol of the pharmaceutical formulation at a rate greater than about 0.53 gram per minute. The aerosol is delivered to the subject via inhalation for the treatment of the pulmonary infection.
Owner:INSMED INC

Compositions, devices, and methods for intranasal delivery of dry powder epinephrine

Intranasal dry powder epinephrine compositions are described herein. The compositions include epinephrine or a pharmaceutically acceptable salt thereof, as well as a stabilizing agent and a carrier. The stabilizing agent is operable to include citric acid, or a pharmaceutically acceptable salt derived therefrom. Such intranasal compositions as described herein are useful in the treatment of health conditions which threaten the central nervous system (CNS) and impede the actions of alpha and beta-adrenergic receptors. Such health conditions include anaphylaxis, bronchospasms, respiratory impairment, organophosphate poisoning, and major adverse cardiac events (MACE).
Owner:BELHAVEN BIOPHARMA INC

Intelligent bronchus endoscope focus detection method, computer equipment and storage medium

The invention discloses an intelligent bronchial endoscope focus detection method, computer equipment and a storage medium. The intelligent bronchial endoscope focus detection method comprises the steps that real, reliable and diversified bronchial endoscope examination images are collected; through data preprocessing, labeling and data division, a bronchial focus detection data set is constructed; an efficient bronchial focus detection network is constructed, and improvement is carried out through multiple attention mechanisms and a convolution module; designing a loss function and training the network to obtain an optimized bronchial focus detection model; and performing focus detection on the acquired image in the real-time bronchoscopy video, and displaying a result. Based on the deep learning technology, the deep neural network model is trained to carry out precise focus type detection on the bronchial endoscope image, real-time bronchial lesion prompt information is provided for endoscope operators, the lesion omission problem during bronchial lesion examination is effectively relieved, the bronchoscopy process is standardized, the endoscope examination quality is improved, and the bronchial lesion detection efficiency is improved. And the workload of operators is reduced.
Owner:XIDIAN UNIV

Application of traditional Chinese medicine composition in preparation of medicine for treating or preventing chronic obstructive pulmonary disease

The invention relates to an application of a traditional Chinese medicine composition in preparation of a medicine for treating or preventing chronic obstructive pulmonary disease (COPD), which is characterized in that the traditional Chinese medicine composition comprises 5-15 parts of antelope horn or 50-150 parts of cornu gorais, 10-60 parts of bulbus fritillariae ussuriensis, 15-60 parts of rheum officinale, 7-30 parts of scutellaria baicalensis, 7-30 parts of lapis chloriti, 10-50 parts of gypsum, 5-20 parts of calculus bovis factitius and 15-60 parts of liquorice. The traditional Chinese medicine composition has a certain treatment effect on COPD, and can significantly improve the lung function of a COPD rat and significantly reduce the level of serum inflammatory factors. Meanwhile, COPD (chronic obstructive pulmonary disease) rat lung and bronchitis injury can be remarkably relieved, secretion of bronchial epithelial goblet cell acidic mucoprotein is reduced, the proportion of lung proinflammatory cells is reduced, and the proportion of inflammatory inhibition cells is increased. In addition, the preparation method of the traditional Chinese medicine composition is simple, rapid, efficient and easy to operate. The prepared mixture, tablet, capsule, pellet and the like are convenient to carry and take.
Owner:JIANGSU KANION PHARMA CO LTD

Spray-dried inhalable biotherapeutics for treatment of disease

The technology described herein relates to a spray-dried biotherapeutic matrix composition comprising a bacterial formulation formulated for administration by inhalation. Also described herein are unit dosage forms of such spray-dried biotherapeutic matrix compositions, devices comprising such pharmaceutical compositions, methods of producing such pharmaceutical compositions, and methods of using such spray-dried biotherapeutic matrix compositions in the treatment of diseases, such as bronchial pulmonary diseases, etc.
Owner:ALVEOLUS BIO INC

Leuconostoc mesenteroides Jonggajibkimchi subspecies CGMCC (China General Microbiological Culture Collection Center) No.30904 and application thereof

The invention discloses a leuconostoc mesenteroides substrain, the preservation number of the strain is CGMCC (China General Microbiological Culture Collection Center) No.30904, the preservation date is June 7, 2024, the preservation classification is named as leuconostoc mesenteroides, and the preservation unit is the General Microbiological Culture Collection Center of the China Committee for Culture Collection of Microorganisms. The strain provided by the invention is harmless to animals, and has the remarkable effects of relieving lung tissue inflammatory infiltration caused by bronchial asthma, reducing release of serum IgE and Th2 type cell factors, inhibiting excessive lung macrophage replacement activation and improving allergic airway inflammation.
Owner:ICDC CHINA CDC

Cough and asthma relieving compound medicine for nebulization treatment of respiratory system as well as preparation and application of cough and asthma relieving compound medicine

The invention provides a cough and asthma relieving compound medicine for nebulization treatment of a respiratory system as well as preparation and application of the cough and asthma relieving compound medicine. The cough and asthma relieving compound medicine takes various traditional Chinese medicinal materials such as ginkgo and ephedra as main raw materials, and further comprises compound bacteria, an osmotic pressure regulator and a cosolvent. The compound bacteria are prepared from cordyceps sinensis, bamboo fungus and pine olive in a specific mass ratio, the osmotic pressure regulator is prepared from glucose and glycerol in a specific ratio, and the cosolvent has multiple selectable components. The preparation method comprises a plurality of steps and unique processes including medicinal material extraction, salifying modification, ultrasonic extraction and the like. Clinical tests show that compared with a control group and a placebo group, the compound medicine disclosed by the invention can remarkably improve lung function related indexes of patients and reduce the level of inflammatory factors, and a visual simulation scoring method also proves that the compound medicine can effectively relieve symptoms of cough and asthma. The medicine can be used for preparing aerosol inhalation medicines for treating various respiratory diseases such as bronchial asthma and chronic obstructive pulmonary diseases, and has a good application prospect.
Owner:GUANGDONG PROVINCIAL HOSPITAL OF TRADITIONAL CHINESE MEDICINE HAINAN HOSPITAL

Bifidobacterium bifidum and application thereof in improving asthma and histamine intolerance

ActiveCN119144528AReduce receptor activationreduce remodelingBacteriaAntinoxious agentsBiotechnologyHistamine intolerance
The invention discloses bifidobacterium bifidum and application thereof in improving asthma and histamine intolerance, and belongs to the technical field of marine microorganisms. The bifidobacterium bifidum NHNK-618 is preserved in the China Center for Type Culture Collection on August 9, 2024, and the preservation number of the bifidobacterium bifidum NHNK-618 is CCTCC (China Center for Type Culture Collection) NO: M20241761. The NHNK-618 has the functions of regulating asthma-related flora, agglutinating asthma-related pathogenic bacteria, reducing staphylococcus aureus enterotoxin, reducing bronchial histamine receptor activation, promoting bronchial barrier integrity, reducing airway remodeling and degrading histamine, and in addition, an NHNK-618 thallus biological membrane can improve the colonization capability on intestinal epithelial cells. The compound can be used for preparing products for improving asthma and histamine intolerance.
Owner:QINGDAO NOVO NUOKANG BIOTECHNOLOGY CO LTD

Bronchial asthma symptom intelligent monitoring method and system based on multi-source data

The invention discloses a bronchial asthma symptom intelligent monitoring method and system based on multi-source data, and relates to the technical field of artificial intelligence, and the method comprises the steps: obtaining multi-mode asthma data after time-space alignment; performing weighted fusion on the western medicine index, the environment index, the tongue condition index and the pulse condition index by using a preset pathogenesis mapping rule to generate an asthma pathology state vector; inputting the asthma pathology state vector into an emergency response channel, analyzing abnormal change of short-term peak flow velocity, synchronously inputting into a chronic evolution channel to track long-term change of tongue condition and pulse condition, and generating emergency response integral and syndrome integral; and superposing the emergency response integral and the syndrome integral on a time axis, and triggering risk assessment when the emergency response integral and the syndrome integral meet the time condition coincidence and the peak flow rate declines to reach an early warning threshold value. According to the method, asthma pathology state vectors are respectively input into an emergency response channel and a chronic evolution channel, so that synchronous monitoring and dynamic modeling of acute attack and chronic disease courses are realized.
Owner:CHINA JAPAN FRIENDSHIP HOSPITAL

Bronchial classification method and device based on graph structure

The invention discloses a bronchus classification method and device based on a graph structure, and the method comprises the steps: obtaining lung image sample data, and extracting a binarization segmentation mask of a bronchus, so as to obtain a bronchus mask image; inputting into a convolutional neural network for prediction to obtain a high-dimensional convolutional feature and a first bronchial segmentation result; skeletonizing the bronchial mask image to obtain point-by-point coordinate features; combining the point-by-point coordinate features and the high-dimensional convolution features, and inputting the combined features into a point voxel graph neural network for prediction to obtain a second bronchial segmentation result; and carrying out iterative training on a convolutional neural network and a point voxel neural network based on the first bronchial segmentation result and the second bronchial segmentation result, and carrying out segmentation processing on the actual lung image to be segmented through the trained convolutional neural network. The point voxel neural network is utilized to guide the learning process of the convolutional neural network through the convolutional features, so that the classification performance can be improved.
Owner:SHENZHEN RES INST OF BIG DATA

Exosome-like nano-vesicles derived from plant radix astragali and preparation method and application of exosome-like nano-vesicles

The invention relates to a plant astragalus membranaceus-derived exosome-like nano-vesicle as well as a preparation method and application thereof. The nano-vesicle is prepared by chopping astragalus membranaceus roots, juicing, carrying out differential-ultra-high-speed centrifugation and filtering. The nano vesicle disclosed by the invention has good biocompatibility and immunomodulatory activity, can be used for intervening bronchial asthma, and shows a relatively good treatment effect; the nano-vesicle can be used as a novel natural plant-derived drug delivery system, and the problems of poor stability, single action mechanism, low delivery efficiency and the like of traditional Chinese medicine components are solved.
Owner:SHANGHAI TONGJI HOSPITAL

COMPOSITIONS AND METHODS FOR SARS CoV-2 RNA DETECTION

Compositions and methods for enriching, isolating, and / or detecting SARS-CoV-2 RNA in a sample are provided. The compositions include the nucleocapsid (N) protein derived from SARS-CoV-2 virus, or a functional fragment or variant thereof, preferably having one or both of R203K and G204R mutations. The compositions are brought in contact with a sample obtained from a subject. The disclosed compositions can be use in methods of detecting SARS-CoV-2 nucleic acids in a sample such as mucus, sputum (processed or unprocessed), bronchial alveolar lavage (BAL), bronchial wash (BW), bodily fluids, cerebrospinal fluid (CSF), urine, tissue (e.g., biopsy material), rectal swab, nasopharyngeal aspirate, nasopharyngeal swab, throat swab, feces, plasma, serum, or whole blood, thus, methods of detecting SARS-CoV-2 in such samples are also provided.
Owner:KING ABDULLAH UNIV OF SCI & TECH

Expiratory gas metabolism marker for evaluating attack severity of bronchial asthma patient and screening method

The invention relates to an exhaled gas metabolism marker for evaluating attack severity of a bronchial asthma patient and a screening method of the exhaled gas metabolism marker. The marker is acetic acid. The screening method of the exhaled gas metabolism marker for evaluating the severity of the attack of the bronchial asthma patients comprises the following steps: respectively collecting exhaled gas of the bronchial asthma patients with mild continuous attack and moderate continuous attack as analysis samples; analyzing each exhaled gas sample by using HPPI-TOFMS to obtain an original mass spectrum of each exhaled gas sample; preprocessing the original mass spectrum of each expired gas sample to obtain data containing relative intensity information of metabolites; carrying out univariate and multivariate analysis on the data containing the relative intensity information of the metabolites, and screening out differential metabolites; a metabolite with the largest difference is screened out through binary logistic regression analysis, and the metabolite is the marker. The method is simple to operate, can efficiently and objectively evaluate the severity of the attack of the bronchial asthma patient, and has important clinical application value.
Owner:AFFILIATED ZHONGSHAN HOSPITAL OF DALIAN UNIV

Application of oncostatin M neutralizing antibody in preparation of medicine for treating bronchial pulmonary dysplasia

The invention discloses application of a neutralizing antibody of oncostatin M in preparation of a medicine for treating bronchial pulmonary dysplasia. The application proves that the intrauterine inflammation can cause BPD-like lung lesion to the filial generation mouse, and the OSM expression level in the mouse lung tissue one day after the intrauterine inflammation filial generation is grown is obviously higher than that of a control group; the OSM level of the BPD group is higher than that of the non-BPD group in the umbilical blood sample of the premature infant; in-vitro experiments show that the OSM treatment can cause lung epithelial cell injury; by dripping a recombined OSM neutralizing antibody into the nose of a newborn mouse, down-regulation of the OSM level in the lung of the mouse is realized, filial generation lung injury induced by the intrauterine inflammation can be repaired, and the OSM can be used as a treatment target of the BPD caused by the intrauterine inflammation.
Owner:THE INTERNATIONAL PEACE MATERNITY & CHILD HEALTH HOSPITAL OF CHINA WELFARE INSTITUTE

Comprehensive nursing bed for bronchial asthma patient

The invention relates to a comprehensive nursing bed for bronchial asthma patients, which belongs to the technical field of medical instruments and comprises a combined movable bed body, a bed position adjusting device, an induction monitoring pillow, a movable asthma nursing table and a central controller. A comprehensive nursing bed with an automatic sleeping posture adjusting structure, an asthma induction factor isolation structure and a real-time monitoring nursing structure is arranged, and a mobile asthma nursing table capable of performing automatic nursing when a patient sleeps soundly is combined with an airflow induction machine; comprehensive automatic nursing can be carried out on an asthma patient in the deep sleep period prone to diseases, the breathing airflow condition of the asthma patient can be monitored in real time so as to judge whether the patient suffers from diseases or not, the three-section type automatic lifting and deflection bed body is utilized, semi-reclining sleeping posture adjustment can be conveniently and rapidly carried out on the patient, and the working efficiency is improved. Therefore, the nursing operation of the asthma patient is greatly simplified, and the nursing efficiency is improved.
Owner:THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV

Intelligent monitoring method and system for children's bronchial asthma symptoms based on multi-source data

The present invention discloses a method and system for intelligent monitoring of bronchial asthma symptoms in children based on multi-source data, which relates to the field of medical technology, including obtaining historical physiological monitoring data and historical asthma information, classifying historical physiological monitoring data based on historical asthma information, and obtaining physiological monitoring data classification information. The present invention uses a data deviation evaluation coefficient to screen historical data, obtain baseline physiological parameters, and achieve accurate analysis of children's physiological states, so as to facilitate timely discovery of abnormal physiological data and improve the efficiency of asthma symptom monitoring. Through the environmental impact coefficient, the impact of the environment on physiological data during asthma is accurately analyzed, so as to accurately set the physiological monitoring threshold, ensure the stability and reliability of the monitoring system, and accurately adjust asthma monitoring in abnormal environments through breathing audio data, ensuring a rapid response to asthma symptom warnings.
Owner:SOOCHOW UNIV AFFILIATED CHILDRENS HOSPITAL

Preparation and usage method of inactivated vaccine composition for progressive atrophic rhinitis

PCT designated stage expiredWO2025020119A1Bacterial antigen ingredientsAntibacterial agentsPasteurella multocida toxinAdjuvant
The present invention belongs to the technical field of veterinary biological products, and specifically relates to a preparation and usage method of an inactivated vaccine composition for progressive atrophic rhinitis. The inactivated vaccine composition for progressive atrophic rhinitis comprises swine toxigenic Pasteurella multocida (ZXT+Pm), swine Bordetella bronchiseptica (AHBb), N-terminal and C-terminal proteins of toxigenic Pasteurella multocida toxin (PMT) (rPMT-N and rPMT-C) and a carbomer water adjuvant.
Owner:ANHUI SCI & TECH UNIV +1

Bifidobacterium longum subsp. Longum and application thereof in improving asthma and high histamine level

ActiveCN119144530ABacteriaDigestive systemBiotechnologyStaphylococcus aureus enterotoxin
The invention discloses bifidobacterium longum subsp. Longum and application thereof in improving asthma and high histamine level, and belongs to the technical field of marine microorganisms. The invention discloses a bifidobacterium longum subsp. Longum NHNK-619, which is preserved in the China Center for Type Culture Collection on August 9, 2024, and the preservation number of the bifidobacterium longum subsp. Longum NHNK-619 is CCTCC (China Center for Type Culture Collection) NO: M20241760. The NHNK-619 has the functions of regulating asthma-related flora, agglutinating asthma-related pathogenic bacteria, reducing staphylococcus aureus enterotoxin, reducing bronchial histamine receptor activation, promoting bronchial barrier integrity, reducing airway remodeling and degrading histamine, and a thallus biofilm formed by the NHNK-619 can improve the colonization ability to intestinal epithelial cells. The compound can be used for preparing products for improving asthma and high histamine level.
Owner:QINGDAO NOVO NUOKANG BIOTECHNOLOGY CO LTD

Lung ventilation function detection system based on algorithm analysis

The invention relates to the technical field of lung function detection, and particularly discloses a lung ventilation function detection system based on algorithm analysis, which adopts a data processing technology based on deep learning to carry out data analysis on breathing parameters of a patient, extracts semantic embedding feature representation of each breathing parameter data item, and obtains a semantic embedding feature representation of each breathing parameter data item; and on the basis of the semantic association topological relation among the breathing parameter data items, global depth association coding is performed on the semantic embedding features of the breathing parameter data items, so that global depth perception of the breathing state of the patient is realized, and whether the patient suffers from bronchial asthma or not is intelligently identified. In this way, the limitation of a traditional data analysis method can be effectively overcome, the dependence on professional knowledge of doctors is reduced, the accuracy and efficiency of pulmonary ventilation function detection are improved, and the risks of misdiagnosis and missed diagnosis are reduced.
Owner:ZHEJIANG HOSPITAL

Therapy for alpha-1 antitrypsin deficiency

PCT designated stage expiredWO2025014986A2Animals/human peptidesDsDNA virusesDiseaseFibrosis
A therapeutic genetic construct for addressing alpha-1 antitrypsin deficiency (AATD) and associated disorders. The genetic construct encodes: (a) a first pre-miRNA; (b) a second pre-miRNA; and (c) a transgene encoding AAT(M). The pre-miRNAs inhibit the expression of alleles encoding mutant variants of AAT, such as AAT(Z), AAT(S), AAT(I), AAT(Siiyama), and AAT(Mmalton). The construct may further comprise a liver-specific promoter. A vector, such as a gorilla adenoviral vector, comprising the genetic construct. A method of treating a disease or disorder, such as COPD, bronchiectasis, neonatal cholestasis, cirrhosis, fibrosis, and hepatocellular carcinoma, comprising administering a therapeutically effective amount of the aforementioned vector. A use of the genetic construct in the manufacture of a medicament for use in treating a disease or disorder. A composition comprising the genetic construct. A kit comprising the genetic construct.
Owner:PRECIGEN INC

A percutaneous lung puncture path planning method based on pulmonary segment level blood vessel structure constraint

The application discloses a percutaneous lung puncture path planning method and device based on lung segment level blood vessel structure constraint, and the method comprises the following steps: performing isotropic resampling, lung lobe segmentation and bronchial tree extraction on CT image data to generate a three-dimensional lung dissection model; inputting the three-dimensional lung dissection model into a lung segment semantic segmentation module to output a lung segment boundary; reconstructing the topological connection relationship between lung segment level blood supply arteries and drainage veins from the lung segment boundary to obtain a structured lung segment level blood vessel atlas; constructing a dynamic puncture risk field voxel map according to the structured lung segment level blood vessel atlas; sampling a plurality of candidate needle entry points in a surface feasible needle entry region to generate an initial path set in the three-dimensional lung dissection model; and weighting the path length, cumulative risk value, puncture angle penalty and high-density lung tissue volume according to a multi-objective optimization function to output a final puncture path. The application significantly improves the safety boundary and clinical applicability of percutaneous lung puncture.
Owner:TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH

Application of SRT2104 in the preparation of drugs for treating bronchial asthma

The present invention discloses the use of SRT2104 in the preparation of a drug for treating bronchial asthma, and relates to the technical field of bronchial asthma treatment. The present invention comprehensively evaluates the activation effect of SRT2104 on airway epithelial SIRT1 and the relief effect on asthmatic airway inflammation under asthma conditions, confirms the effectiveness of SRT2104 in activating airway epithelial SIRT1 and controlling asthmatic airway inflammation under asthma conditions, and lays a foundation for the discovery of clinical medical targets and the development of drugs in the treatment of bronchial asthma.
Owner:SHUNDE WOMEN & CHILDRENS HOSPITAL OF GUANGDONG MEDICAL UNIV (MOTHER & CHILD HEALTH HOSPITAL SHUNDE DISTRICT FOSHAN CITY)